U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C16H18O9
Molecular Weight 354.3087
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of CHLOROGENIC ACID, (Z)-

SMILES

O[C@@H]1C[C@](O)(C[C@@H](OC(=O)\C=C/C2=CC=C(O)C(O)=C2)[C@@H]1O)C(O)=O

InChI

InChIKey=CWVRJTMFETXNAD-XYXZIBEBSA-N
InChI=1S/C16H18O9/c17-9-3-1-8(5-10(9)18)2-4-13(20)25-12-7-16(24,15(22)23)6-11(19)14(12)21/h1-5,11-12,14,17-19,21,24H,6-7H2,(H,22,23)/b4-2-/t11-,12-,14-,16+/m1/s1

HIDE SMILES / InChI
Z-Chlorogenic acid better known as cis-5-caffeoylquinic acid is a cinnamate ester formed by condensation fo the carboxy group of cis-caffeic acid with the 5-hydroxy group of (+)-quinic acid. It is a naturally occurring isomer of Chlorogenic acid and can be extracted from Nerium indicum flowers, coffee plant, Purpurascen leaves, Artemisia pectinata, and tobacco. In some but not all extractions cis-5caffeoylquinic content is increased after UV exposure of plant or cells.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: Q16665
Gene ID: 3091.0
Gene Symbol: HIF1A
Target Organism: Homo sapiens (Human)
Target ID: Q9NYA1
Gene ID: 8877.0
Gene Symbol: SPHK1
Target Organism: Homo sapiens (Human)
44.87 µM [EC50]
62.33 µM [EC50]
Conditions
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
0.7638 ng/mL
3.64 mg single, oral
dose: 3.64 mg
route of administration: Oral
experiment type: SINGLE
co-administered: TAUROCHOLIC ACID
CHLOROGENIC ACID plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
0.6637 ng/mL
3.64 mg 3 times / day steady-state, oral
dose: 3.64 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered: TAUROCHOLIC ACID
CHLOROGENIC ACID plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
2376 ng/mL
3 mg/kg single, intramuscular
dose: 3 mg/kg
route of administration: Intramuscular
experiment type: SINGLE
co-administered:
CHLOROGENIC ACID plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
2914 ng/mL
3 mg/kg 1 times / day multiple, intramuscular
dose: 3 mg/kg
route of administration: Intramuscular
experiment type: MULTIPLE
co-administered:
CHLOROGENIC ACID plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
1.135 ng × h/L
3.64 mg single, oral
dose: 3.64 mg
route of administration: Oral
experiment type: SINGLE
co-administered: TAUROCHOLIC ACID
CHLOROGENIC ACID plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
1.782 ng × h/L
3.64 mg 3 times / day steady-state, oral
dose: 3.64 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered: TAUROCHOLIC ACID
CHLOROGENIC ACID plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
6124 ng × h/mL
3 mg/kg single, intramuscular
dose: 3 mg/kg
route of administration: Intramuscular
experiment type: SINGLE
co-administered:
CHLOROGENIC ACID plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
7199 ng × h/mL
3 mg/kg 1 times / day multiple, intramuscular
dose: 3 mg/kg
route of administration: Intramuscular
experiment type: MULTIPLE
co-administered:
CHLOROGENIC ACID plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
1.3 h
3.64 mg single, oral
dose: 3.64 mg
route of administration: Oral
experiment type: SINGLE
co-administered: TAUROCHOLIC ACID
CHLOROGENIC ACID plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
1.4 h
3.64 mg 3 times / day steady-state, oral
dose: 3.64 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered: TAUROCHOLIC ACID
CHLOROGENIC ACID plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
1 h
3 mg/kg single, intramuscular
dose: 3 mg/kg
route of administration: Intramuscular
experiment type: SINGLE
co-administered:
CHLOROGENIC ACID plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
1.2 h
3 mg/kg 1 times / day multiple, intramuscular
dose: 3 mg/kg
route of administration: Intramuscular
experiment type: MULTIPLE
co-administered:
CHLOROGENIC ACID plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
OverviewDrug as perpetrator​Drug as victimTox targets
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Dietary effects on the uptake of benzo[a]pyrene.
1994 Aug
Action of chlorogenic acid on the complement system.
1999
Steroid hormone activity of flavonoids and related compounds.
2000 Jul
LC/ES-MS detection of hydroxycinnamates in human plasma and urine.
2001 Apr
Effect of antioxidants, oxidants, metals and saliva on cytotoxicity induction by sodium fluoride.
2003 Sep-Oct
Gastrointestinally distributed UDP-glucuronosyltransferase 1A10, which metabolizes estrogens and nonsteroidal anti-inflammatory drugs, depends upon phosphorylation.
2004 Jul 2
Apple phytochemicals and their health benefits.
2004 May 12
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods.
2006 Nov
Profiling the phenolic compounds of Artemisia pectinata by HPLC-PAD-MSn.
2008 Jul-Aug
Interaction of cinnamic acid derivatives with commercial hypoglycemic drugs on 2-deoxyglucose uptake in 3T3-L1 adipocytes.
2011 Sep 28
Looking for the physiological role of anthocyanins in the leaves of Coffea arabica.
2012 Jul-Aug
Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway.
2013 Jan 7
Separation and Identification of Phenolic Acid and Flavonoids from Nerium indicum Flowers.
2015 Jan-Feb
Acetaminophen hepatotoxicity and sterile inflammation: The mechanism of protection of Chlorogenic acid.
2016 Jan 5
Patents

Sample Use Guides

In a phase II trial Chlorogenic acid was administered to patients with impaired glucose tolerance. Chlorogenic acid was provided as three 400 mg capsules taken a half hour before meals for 90 days.
Route of Administration: Oral
DU145 cells were maintained in RPMI1640 medium supplemented with 10% fetal bovine serum and penicillin/streptomycin and incubated at 37 deg-C in an atmosphere with 5% CO2. Hypoxic conditions were established in an anaerobic chamber flushed with 1% oxygen, 5% CO2, and 94% nitrogen. Cells were incubated with 50 uM chlorogenic acid in hypoxic conditions for 4 hours to determine the effect of chlorogenic acid on HIF-1a. Chlorogenic acid significantly reduced the hypoxia-induced expression of HIF-1a and expression of Sphingosine Kinase 1 (SPHK-1) returned to normoxic levels. Cells were also treated with various concentrations of chlorogenic acid (0 - 100 uM) for 24 hours and cell viability was decreased by 20%.
Name Type Language
CHLOROGENIC ACID, (Z)-
Common Name English
CHLOROGENIC ACID Z-FORM [MI]
Common Name English
CIS-CHLOROGENIC ACID
Common Name English
CYCLOHEXANECARBOXYLIC ACID, 3-(((2Z)-3-(3,4-DIHYDROXYPHENYL)-1-OXO-2-PROPEN-1-YL)OXY)-1,4,5-TRIHYDROXY-, (1S,3R,4R,5R)-
Systematic Name English
Code System Code Type Description
CAS
15016-60-1
Created by admin on Sat Dec 16 08:24:28 GMT 2023 , Edited by admin on Sat Dec 16 08:24:28 GMT 2023
PRIMARY
FDA UNII
037SV4IVWA
Created by admin on Sat Dec 16 08:24:28 GMT 2023 , Edited by admin on Sat Dec 16 08:24:28 GMT 2023
PRIMARY
PUBCHEM
1794425
Created by admin on Sat Dec 16 08:24:28 GMT 2023 , Edited by admin on Sat Dec 16 08:24:28 GMT 2023
PRIMARY
CHEBI
75489
Created by admin on Sat Dec 16 08:24:28 GMT 2023 , Edited by admin on Sat Dec 16 08:24:28 GMT 2023
PRIMARY
MERCK INDEX
m3413
Created by admin on Sat Dec 16 08:24:28 GMT 2023 , Edited by admin on Sat Dec 16 08:24:28 GMT 2023
PRIMARY